ARKG
ARK Genomic Revolution ETF
3월 13일 4:00 PM ET (한국 3/14 05:00)
$26.36
+0.19 ▲ +0.73%
🌙 3월 13일 7:52 PM ET (한국 3/14 08:52)
$26.37
+0.01 ▲ +0.03%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -6.26% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -8.28% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | -15.43% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 8.81 | Perf Half Y | 0.65% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 23.97M | Perf YTD | -9.01% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -23.35% ($34.39) | Perf Year | 19.66% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 50.59% ($17.50) | Perf 3Y | -7.44% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 3.77% 3.77% | Perf 5Y | -71.1% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.14 | Perf 10Y | 66.48% |
| Dividend Ex-Date | 2021/12/29 | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 35.11 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -8.47% ($28.8) | Beta | 1.73 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -12.11% ($29.99) | Rel Volume | 1.08 | Prev Close | $26.17 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -4.9% ($27.72) | Avg Volume(3M) | 2.72M | Price | $26.36 |
| IPO | 2014/10/31 | Option/Short | Yes/Yes | Trades | 15979 | Volume | 2,924,839 | Change | 0.73% |
뉴스 로딩 중...